Long-term and low-grade safety results of a phase III study (PARAMOUNT): maintenance Pemetrexed plus best supportive care versus placebo plus best supportive care immediately after induction treatment with Pemetrexed plus Cisplatin for advanced nonsquamous non-small-cell lung cancer

Gespeichert in:
Bibliographische Detailangaben
Weitere Verfasser: Pujol, Jean-Louis (BerichterstatterIn) , Thomas, Michael (BerichterstatterIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2014
In: Clinical lung cancer
Year: 2014, Jahrgang: 15, Heft: 6, Pages: 418-425
ISSN:1938-0690
DOI:10.1016/j.cllc.2014.06.007
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1016/j.cllc.2014.06.007
Volltext
Verfasserangaben:Jean-Louis Pujol, Luis Paz-Ares, Filippo de Marinis, Mircea Dediu, Michael Thomas, Paolo Bidoli, Jesus Corral, Belen San Antonio, Nadia Chouaki, William John, Annamaria Zimmermann, Carla Visseren-Grul, Cesare Gridelli

MARC

LEADER 00000caa a2200000 c 4500
001 1522036385
003 DE-627
005 20220812105642.0
007 cr uuu---uuuuu
008 151116s2014 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.cllc.2014.06.007  |2 doi 
035 |a (DE-627)1522036385 
035 |a (DE-576)452036380 
035 |a (DE-599)BSZ452036380 
035 |a (OCoLC)1340730630 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
084 |a 33  |2 sdnb 
245 0 0 |a Long-term and low-grade safety results of a phase III study (PARAMOUNT)  |b maintenance Pemetrexed plus best supportive care versus placebo plus best supportive care immediately after induction treatment with Pemetrexed plus Cisplatin for advanced nonsquamous non-small-cell lung cancer  |c Jean-Louis Pujol, Luis Paz-Ares, Filippo de Marinis, Mircea Dediu, Michael Thomas, Paolo Bidoli, Jesus Corral, Belen San Antonio, Nadia Chouaki, William John, Annamaria Zimmermann, Carla Visseren-Grul, Cesare Gridelli 
264 1 |c 2014 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 13.11.2015 
700 1 |a Pujol, Jean-Louis  |0 (DE-588)1078893713  |0 (DE-627)839773889  |0 (DE-576)452037182  |4 oth 
700 1 |a Thomas, Michael  |0 (DE-588)1054438781  |0 (DE-627)79152213X  |0 (DE-576)41027089X  |4 oth 
773 0 8 |i In  |t Clinical lung cancer  |d Dallas, Tex. : Cancer Information Group, 1999  |g 15(2014), 6, Seite 418-425  |h Online-Ressource  |w (DE-627)49143846X  |w (DE-600)2193644-4  |w (DE-576)358410746  |x 1938-0690  |7 nnas  |a Long-term and low-grade safety results of a phase III study (PARAMOUNT) maintenance Pemetrexed plus best supportive care versus placebo plus best supportive care immediately after induction treatment with Pemetrexed plus Cisplatin for advanced nonsquamous non-small-cell lung cancer 
773 1 8 |g volume:15  |g year:2014  |g number:6  |g pages:418-425  |g extent:8  |a Long-term and low-grade safety results of a phase III study (PARAMOUNT) maintenance Pemetrexed plus best supportive care versus placebo plus best supportive care immediately after induction treatment with Pemetrexed plus Cisplatin for advanced nonsquamous non-small-cell lung cancer 
856 4 0 |u http://dx.doi.org/10.1016/j.cllc.2014.06.007  |x Verlag  |x Resolving-System  |3 Volltext 
951 |a AR 
992 |a 20151116 
993 |a Article 
994 |a 2014 
998 |g 1054438781  |a Thomas, Michael  |m 1054438781:Thomas, Michael  |d 910000  |d 950000  |d 950900  |e 910000PT1054438781  |e 950000PT1054438781  |e 950900PT1054438781  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |p 5 
999 |a KXP-PPN1522036385  |e 2873366303 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Gesehen am 13.11.2015"],"language":["eng"],"relHost":[{"recId":"49143846X","physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 04.02.20"],"titleAlt":[{"title":"Lung cancer"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"pubHistory":["1.1999/2000 -"],"language":["eng"],"id":{"eki":["49143846X"],"issn":["1938-0690"],"zdb":["2193644-4"]},"part":{"text":"15(2014), 6, Seite 418-425","year":"2014","pages":"418-425","issue":"6","volume":"15","extent":"8"},"origin":[{"publisher":"Cancer Information Group","dateIssuedKey":"1999","publisherPlace":"Dallas, Tex.","dateIssuedDisp":"1999-"}],"title":[{"title":"Clinical lung cancer","title_sort":"Clinical lung cancer"}],"disp":"Long-term and low-grade safety results of a phase III study (PARAMOUNT) maintenance Pemetrexed plus best supportive care versus placebo plus best supportive care immediately after induction treatment with Pemetrexed plus Cisplatin for advanced nonsquamous non-small-cell lung cancerClinical lung cancer"}],"recId":"1522036385","physDesc":[{"extent":"8 S."}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"name":{"displayForm":["Jean-Louis Pujol, Luis Paz-Ares, Filippo de Marinis, Mircea Dediu, Michael Thomas, Paolo Bidoli, Jesus Corral, Belen San Antonio, Nadia Chouaki, William John, Annamaria Zimmermann, Carla Visseren-Grul, Cesare Gridelli"]},"title":[{"title_sort":"Long-term and low-grade safety results of a phase III study (PARAMOUNT)","title":"Long-term and low-grade safety results of a phase III study (PARAMOUNT)","subtitle":"maintenance Pemetrexed plus best supportive care versus placebo plus best supportive care immediately after induction treatment with Pemetrexed plus Cisplatin for advanced nonsquamous non-small-cell lung cancer"}],"origin":[{"dateIssuedKey":"2014","dateIssuedDisp":"2014"}],"id":{"eki":["1522036385"],"doi":["10.1016/j.cllc.2014.06.007"]},"person":[{"role":"oth","display":"Pujol, Jean-Louis","family":"Pujol","given":"Jean-Louis"},{"role":"oth","display":"Thomas, Michael","family":"Thomas","given":"Michael"}]} 
SRT |a LONGTERMAN2014